* Data elements with asterisks are not required for accreditation purposes for the Commission on Cancer. These elements may be clinically important, but are not yet validated or regularly used in patient management. Alternatively, the necessary data may not be available to the pathologist at the time of pathologic assessment of this specimen. 
Explanatory Notes

A. Application
The ampulla of Vater is a complex structure that represents the confluence of the distal common bile duct and main pancreatic duct, which traverses the duodenal wall and opens into the duodenal lumen through a small mucosal elevation, the duodenal papilla. Tumors of the ampulla of Vater include tumors arising in the ampulla (intraampullary type), tumors arising on the ampulla (peri-ampullary type), and tumors arising at the junction of the mucosa of the ampulla with that of the papilla or involving both the intra-ampullary and peri-ampullary region of the duodenum (mixed type The term "carcinoma, NOS (not otherwise specified)" is not part of the WHO classification.
# Ampullary tumors of the papillary histologic type have been shown to have a favorable prognosis compared to tumors of non-papillary histologic types.
4,5
## Signet-ring cell carcinomas are, by convention, classified as poorly differentiated (grade 3/4) adenocarcinomas, and poor differentiation has been shown to be an adverse prognostic factor for ampullary carcinomas (see below).
5,6
### Small cell carcinomas and undifferentiated (histologic type) carcinomas are assigned grade 4 (see below).
C. Histologic Grade
For non-papillary adenocarcinomas, the following grading system is suggested: GX Grade cannot be assessed G1
Well differentiated (greater than 95% of tumor composed of glands) G2
Moderately differentiated (50% to 95% of tumor composed of glands) G3
Poorly differentiated # (49% or less of tumor composed of glands) # Poor differentiation has been shown to be an adverse prognostic factor. 5, 6 Grade 4 carcinomas include both undifferentiated carcinomas (histologic type) and small cell carcinoma (high-grade neuroendocrine carcinomas) in the WHO classification (see above).
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D. TNM and Stage Groupings
The TNM staging system for tumors of the ampulla of Vater of the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) is recommended and shown below. 1, 7 The post-resection prognosis of a patient with ampullary carcinoma is primarily determined by the anatomic extent of disease as defined by the TNM classification and stage groupings. [6] [7] [8] [9] [10] [11] By AJCC/UICC convention, the designation "T" refers to a primary tumor that has not been previously treated. The symbol "p" refers to the pathologic classification of the TNM, as opposed to the clinical classification, and is based on gross and microscopic examination. pT entails a resection of the primary tumor or biopsy adequate to evaluate the highest pT category, pN entails removal of nodes adequate to validate lymph node metastasis, and pM implies microscopic examination of distant lesions. Clinical classification (cTNM) is usually carried out by the referring physician before treatment during initial evaluation of the patient or when pathologic classification is not possible.
Pathologic staging is usually performed after surgical resection of the primary tumor. Pathologic staging depends on pathologic documentation of the anatomic extent of disease, whether or not the primary tumor has been completely removed. If a biopsied tumor is not resected for any reason (eg, when technically unfeasible) and if the highest T and N categories or the M1 category of the tumor can be confirmed microscopically, the criteria for pathologic classification and staging have been satisfied without total removal of the primary cancer. Less than 2.5 cm 65%
cm or more 20%
The difference is statistically significant (p=0.039).
## Invasion of the muscle of the sphincter of Oddi has been shown to be an adverse prognostic factor. 
Regional Lymph Nodes (N)
# NX Regional lymph nodes cannot be assessed N0
No regional lymph node metastasis N1
Regional lymph node metastasis # Regional lymph node metastases have been shown to have independent significance as an adverse prognostic factor. 4, 6, 8, 12 The regional nodes may be subdivided as follows.
Superior
Lymph nodes superior to head and body of pancreas Inferior Lymph nodes inferior to head and body of pancreas Anterior Anterior pancreaticoduodenal, pyloric, and proximal mesenteric lymph nodes Posterior Posterior pancreaticoduodenal, common bile duct or pericholedochal, and proximal mesenteric nodes
The following lymph nodes are also considered regional: hepatic artery nodes, infrapyloric nodes, subpyloric nodes, celiac nodes, superior mesenteric nodes, retroperitoneal nodes, and lateral aortic nodes. Tumor involvement of other nodal groups is considered distant metastasis. Anatomic division of regional lymph nodes is not necessary, but separately submitted lymph nodes should be reported as submitted. Stage 0  Tis  N0  M0  Stage IA  T1  N0  M0  Stage IB  T2  N0  M0  Stage IIA  T3  N0  M0  Stage IIB  T1  N1  M0  T2  N1  M0  T3  N1  M0  Stage III  T4  Any N  M0  Stage IV Any T Any N M1
Regional Lymph Nodes (pN0): Isolated Tumor Cells
Stage Groupings
TNM Descriptors
For identification of special cases of TNM or pTNM classifications, the "m" suffix and "y," "r," and "a" prefixes are used. Although they do not affect the stage grouping, they indicate cases needing separate analysis.
The "m" suffix indicates the presence of multiple primary tumors in a single site and is recorded in parentheses: pT(m)NM.
The "y" prefix indicates those cases in which classification is performed during or following initial multimodality therapy (ie, neoadjuvant chemotherapy, radiation therapy, or both chemotherapy and radiation therapy). The cTNM or pTNM category is identified 16 by a "y" prefix. The ycTNM or ypTNM categorizes the extent of tumor actually present at the time of that examination. The "y" categorization is not an estimate of tumor prior to multimodality therapy (ie, before initiation of neoadjuvant therapy).
The "r" prefix indicates a recurrent tumor when staged after a documented disease-free interval, and is identified by the "r" prefix: rTNM.
The "a" prefix designates the stage determined at autopsy: aTNM.
Additional Descriptors
Residual Tumor (R) Tumor remaining in a patient after therapy with curative intent (eg, surgical resection for cure) is categorized by a system known as R classification, shown below.
RX Presence of residual tumor cannot be assessed R0
No residual tumor R1
Microscopic residual tumor R2
Macroscopic residual tumor
For the surgeon, the R classification may be useful to indicate the known or assumed status of the completeness of a surgical excision. For the pathologist, the R classification is relevant to the status of the margins of a surgical resection specimen. That is, tumor involving the resection margin on pathologic examination may be assumed to correspond to residual tumor in the patient and may be classified as macroscopic or microscopic according to the findings at the specimen margin(s).
Vessel Invasion
By AJCC/UICC convention, vessel invasion (lymphatic or venous) does not affect the T category indicating local extent of tumor unless specifically included in the definition of a T category. In all other cases, lymphatic and venous invasion by tumor are coded separately as follows. 
F. Perineural Invasion
Perineural infiltration by tumor has been shown to be an adverse prognostic factor.
5
G. Margins
Local recurrence from invasive carcinoma in the region of the pancreatic head most often occurs at the posterior margin of the pancreatic head. Since this is a critical margin, the protocol recommends inking the posterior retroperitoneal surface of the pancreas and submitting sections through the tumor at its closest approach to this margin. Local recurrence from intraductal tumor, however, is most likely to occur at a ductal resection margin (ie, the main pancreatic duct and/or the common bile duct margin). Thus, complete en face sections through the distal pancreatic margin (representing the distal margin of the main pancreatic duct) and the margin of the common bile duct should also be taken. Involvement of resection margins has been shown to be an adverse prognostic factor. 6, 15 H. Other Evaluation Sections of gastric antrum may be evaluated for gastritis (eg, Helicobacter pylori gastritis, chemical gastritis).
